FDA Brief

Warning letters Food

FDA warning letter to

Lifted Naturals

LowIssued Feb 18, 2021Posted Feb 19, 2021Center for Food Safety and Applied Nutrition (CFSAN)

FDA cites Lifted Naturals' Mood Boosting Probiotic for website claims that make it an unapproved drug.

What happened

FDA reviewed the website www.liftednaturals.com in December 2020 and determined that Lifted Naturals takes orders there for Mood Boosting Probiotic. The website claimed the product's prebiotic was proven to help anxiety, that the probiotic was designed to help mood and anxiety, and that probiotics could be a first line of defense and prevention for mental health issues. FDA concluded the product is intended to treat or prevent disease and is an unapproved new drug (not generally recognized as safe and effective for its claimed uses and not FDA-approved).

What FDA found

  1. Website claims show the probiotic is intended to cure, mitigate, treat, or prevent disease, so FDA treats it as a drug.

    section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 321(g)(1)(B)]
  2. The product is a new drug (a product not generally recognized as safe and effective for its claimed uses) and was introduced into interstate commerce without FDA approval.

    section 201(p) [21 U.S.C. § 321(p)]; sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  3. The product is misbranded (improperly labeled) because it lacks adequate directions for a layperson to use it safely for its intended uses.

    section 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 C.F.R. § 201.5
  4. The misbranded drug was introduced or delivered for introduction into interstate commerce, which violates the law.

    section 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA asks Lifted Naturals to notify it in writing within 15 working days of receipt of the letter about specific steps taken to address the violations, including an explanation and supporting documents. If the company cannot finish within that time, it must state the reason for delay and when it will finish.

Who should pay attention

  • probiotic and supplement brands making mood or anxiety claims
  • online sellers of supplements with disease claims
  • regulatory and marketing staff who review website copy

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk